 Home > Popular Keywords > Keyword List V > vendex 2017

vendex 2017

Your source for the latest vendex 2017 articles. Follow vendex 2017 trends, innovations and developments on echemi.com.

Related Tags

mcat result 2017

[exposure table] 2017 annual analysis report on unqualified drug quality data

 Time of Update: 2018-03-15

Introduction: dear friends who pay attention to yaozhi.com, Hello! According to the announcement database of drug quality nonconformity and relevant information on the official
Hefeng animal husbandry slaughtered nearly 400 million chickens in 2017, so how much does a chicken earn?

 Time of Update: 2018-03-14

In 2017, the company's related businesses achieved sales revenue of 286 million yuan, a year-on-year increase of 19.61%, accounting for 2.09% of the main business income, and the gross profit rate of related businesses was 15.57%.
Performance analysis of multinational pharmaceutical companies in 2017: key words of innovative drugs and Chinese market

 Time of Update: 2018-03-07

[market analysis of China Pharmaceutical network] with the release of 2017 financial statements of multinational pharmaceutical companies, many people in the industry are curious
In 2017, the financing amount of medical devices reached 8 billion yuan

 Time of Update: 2018-03-05

Source: Cypress blue device 2018-03-05 cypress blue device according to the public information, in 2017, there were 67 financing cases with clear financing subjects disclosed
Data release of China's Pharmaceutical Foreign Trade in 2017: the export growth rate reached the highest in five years!

 Time of Update: 2018-03-05

Source: Medical Economic News March 5, 2018 according to the statistics of China Customs, in 2017, China's import and export of medical and health products reached US $116.676
Panoramic perspective of application for registration of biological drugs in 2017, injection accounted for 90.42%

 Time of Update: 2018-03-05

- 2 varieties Eli Lilly Nederland B.V. registered and applied for the import clinical trial of 4 priority review biological products dulaglutide injection, 7 recombinant insulin lysoprotein mixed injection (50R) (3 supplementary applications, 4 import re registration).
Pharmaceutical companies dominated by heparin APIs ushered in 2017 Annual Report

 Time of Update: 2018-03-02

On February 26, Changshan Pharmaceutical Co., Ltd. issued the "2017 annual performance express" that the company's total operating revenue in 2017 reached 1420170000 yuan, an increase of 26.98% over the same period last year.
[exclusive] in 2017, the performance of listed pharmaceutical companies took the lead: the net

 Time of Update: 2018-03-01

2017's pharmaceutical industry is a year of rapid development

New policies are constantly changing, new demands are constantly raised, and new technologies
2017 pharmaceutical giant annual report and blockbuster drug sales statistics

 Time of Update: 2018-03-01

Source: or manufacturing 2018-03-01: the 2017 financial statements of major pharmaceutical enterprises have been published one after another

Based on the top ranking
The top ten developments of Chinese Science in 2017 were released in Beijing

 Time of Update: 2018-02-28

This article is reproduced from the official account of China Academy of Sciences (CASbulletin), and the ten major progress of China science is selected by the Ministry of science
[exclusive] Shuanglu's revenue in 2017 was 1.242 billion yuan, reversing the decline in 2018 or relying on these two drugs to keep climbing!

 Time of Update: 2018-02-28

In addition to the market expansion of existing products, the main focus of Beijing Shuanglu this year is on its heavyweight anti-tumor drug lenalidomide.
Global sales total 21.8 billion US dollars! 26 key imported drugs approved in 2017 to restructure the domestic market

 Time of Update: 2018-02-28

Alfatinib maleate tablets: in February 2017, alfatinib maleate tablets, a lung cancer treatment drug of Boehringer Ingelheim, was approved for import, with the trade name of "giterry" and specifications of 20mg, 30mg, 40mg and 50mg.
In 2017, the financial report of Chongqing Huasen came, with a net profit of 100 million yuan attributable to the parent company

 Time of Update: 2018-02-27

1、 Yesterday (February 26), Chongqing Huasen Pharmaceutical Co., Ltd

(hereinafter referred to as Chongqing Huasen) announced the 2017 annual performance express
2017 evaluation results of Hunan key construction projects published truking science and technology rating

 Time of Update: 2018-02-26

[China Pharmaceutical network enterprise news] recently, the general office of the people's Government of Hunan Province reported the assessment of 2017 provincial key construction
2017 China's innovation drug blowout: 39 imported drugs listed 174 class 1 new drug applications

 Time of Update: 2018-02-26

Source: on February 26, 2018, under the guidance of policies and measures such as deepening drug and medical device reform, implementing priority review policy and expanding drug
Top 50 products in global drug sales in 2017: xiumeile won the "6 crown"

 Time of Update: 2018-02-26

Based on the financial report data published by each company, the author analyzes the top 50 products in global sales volume.
China's innovative drug blowout in 2017! 39 imported drugs are on the market, 174 class 1 new drugs are declared, and new drugs are on the market faster!

 Time of Update: 2018-02-25

According to the report data, in 2017, the number of imported drugs approved reached 39, and the number of domestic class 1 new drug applications reached 174, the highest in nearly 10 years.
Looking back on General Secretary Xi's voice of traditional Chinese medicine in 2017

 Time of Update: 2018-02-22

2017 is a milestone year in the development of the party and the country, and also an important year for the revitalization and development of traditional Chinese medicine
In 2017, the global new drug R & D year, China set a record

 Time of Update: 2018-02-09

The United States also uses a variety of regulatory methods to speed up the development and approval of new drugs, including fast track, breakthrough treatment identification, etc.
Top 10 cases in the field of antibody drugs in 2017: involving about 4.433 billion yuan

 Time of Update: 2018-02-08

Source: huoshichuang 2018-02-08 public data of huoshichuang collation shows that in 2017, there were 19 financing cases in the field of antibody drugs in China, involving a total

Related Keywords

vendex label best soc 2017 prize 2017 2017 filimleri best supercomputer 2017 megatrends 2017 pndf 2017 heavy to 2017

Go to Page

Hot Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

vacu online(27)

vilcek foundation(21)

valvoline close to me(26)

veolia water technologies(25)

viscosity calculator(11)

valsartan and bananas(10)

viagra original use(9)

varsol solvent(10)

versabond white(16)

vitamin b3 sources(6)

What's trending

Top Keywords

v and a online shop

vacancy in seeds company

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.